Inguinal hernia medical therapy: Difference between revisions

Jump to navigation Jump to search
m (Bot: Removing from Primary care)
 
(8 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Inguinal hernia}}
{{Inguinal hernia}}
{{CMG}} {{AE}}
{{CMG}} {{AE}} {{F.K}}
 
{{PleaseHelp}}


==Overview==
==Overview==
Pharmacologic medical therapies for inguinal hernia include [[Pain relievers|pain reliever]], [[antibiotics]], topical medications.


==Medical Therapy==
==Medical Therapy==
*Pharmacologic medical therapies for patients with post-operative repair of inguinal hernia include:<ref name="pmid24920934">{{cite journal |vauthors=Bjurstrom MF, Nicol AL, Amid PK, Chen DC |title=Pain control following inguinal herniorrhaphy: current perspectives |journal=J Pain Res |volume=7 |issue= |pages=277–90 |year=2014 |pmid=24920934 |pmc=4045265 |doi=10.2147/JPR.S47005 |url=}}</ref><ref name="pmid23302973">{{cite journal |vauthors=Cohen SP, Galvagno SM, Plunkett A, Harris D, Kurihara C, Turabi A, Rehrig S, Buckenmaier CC, Chelly JE |title=A multicenter, randomized, controlled study evaluating preventive etanercept on postoperative pain after inguinal hernia repair |journal=Anesth. Analg. |volume=116 |issue=2 |pages=455–62 |year=2013 |pmid=23302973 |doi=10.1213/ANE.0b013e318273f71c |url=}}</ref><ref name="pmid23450576">{{cite journal |vauthors=Derry S, Sven-Rice A, Cole P, Tan T, Moore RA |title=Topical capsaicin (high concentration) for chronic neuropathic pain in adults |journal=Cochrane Database Syst Rev |volume= |issue=2 |pages=CD007393 |year=2013 |pmid=23450576 |doi=10.1002/14651858.CD007393.pub3 |url=}}</ref><ref name="pmid19801049">{{cite journal |vauthors=O'Connor AB, Dworkin RH |title=Treatment of neuropathic pain: an overview of recent guidelines |journal=Am. J. Med. |volume=122 |issue=10 Suppl |pages=S22–32 |year=2009 |pmid=19801049 |doi=10.1016/j.amjmed.2009.04.007 |url=}}</ref>
*Pharmacologic medical therapies for patients with post-operative repair of inguinal hernia include:<ref name="pmid24920934">{{cite journal |vauthors=Bjurstrom MF, Nicol AL, Amid PK, Chen DC |title=Pain control following inguinal herniorrhaphy: current perspectives |journal=J Pain Res |volume=7 |issue= |pages=277–90 |year=2014 |pmid=24920934 |pmc=4045265 |doi=10.2147/JPR.S47005 |url=}}</ref><ref name="pmid23302973">{{cite journal |vauthors=Cohen SP, Galvagno SM, Plunkett A, Harris D, Kurihara C, Turabi A, Rehrig S, Buckenmaier CC, Chelly JE |title=A multicenter, randomized, controlled study evaluating preventive etanercept on postoperative pain after inguinal hernia repair |journal=Anesth. Analg. |volume=116 |issue=2 |pages=455–62 |year=2013 |pmid=23302973 |doi=10.1213/ANE.0b013e318273f71c |url=}}</ref><ref name="pmid23450576">{{cite journal |vauthors=Derry S, Sven-Rice A, Cole P, Tan T, Moore RA |title=Topical capsaicin (high concentration) for chronic neuropathic pain in adults |journal=Cochrane Database Syst Rev |volume= |issue=2 |pages=CD007393 |year=2013 |pmid=23450576 |doi=10.1002/14651858.CD007393.pub3 |url=}}</ref><ref name="pmid19801049">{{cite journal |vauthors=O'Connor AB, Dworkin RH |title=Treatment of neuropathic pain: an overview of recent guidelines |journal=Am. J. Med. |volume=122 |issue=10 Suppl |pages=S22–32 |year=2009 |pmid=19801049 |doi=10.1016/j.amjmed.2009.04.007 |url=}}</ref>
**Pain reliever
** '''1. Pain reliever'''
***Preferred regimen: Non-steroidal antiinflammatory drugs(NSAIDs) 400mg  PO q12h PRN
***Preferred regimen: [[Non-steroidal anti-inflammatory drugs]](NSAIDs) 400mg  PO q12h PRN
***Alternative regimen (1): Gabapentin 300 mg PO q8h PRN
***Alternative regimen (1)[[: Gabapentin]] 300 mg PO q 8h PRN
***Alternative regimen (2): Pregabalin 300 mg PO q8h PRN
***Alternative regimen (2): [[Pregabalin]] 300 mg PO q 8h PRN
***Alternative regimen (5): Opioids 2-10 mg IV q2-4h PRN
***Alternative regimen (5): [[Opioids]] 2-10 mg IV q 2-4h PRN
***Alternative regimen (6): Tramadol 50-100mg PO q4-6h PRN
***Alternative regimen (6): [[Tramadol]] 50-100 mg PO q 4-6h PRN
***Alternative regimen (3): Duloxetine 30 mg PO q24h for 1 week
***Alternative regimen (3): [[Duloxetine]] 30 mg PO q 24h for 1 week
***Alternative regimen (4): Venlafaxine 75-225 mg PO q24h for 1 week
***Alternative regimen (4): [[Venlafaxine]] 75-225 mg PO q 24h for 1 week
**Antibiotics
** '''2. Antibiotics'''
***Preferred regimen: Cefazolin 2 g IV
***Preferred regimen: [[Cefazolin]] 2 g IV for 7 days
***Alternative regimen (1): Clindamycin 900 mg
***Alternative regimen (1): [[Clindamycin]] 900 mg q 8h for 7 days
***Alternative regimen (2): Vancomycin 15 mg/kg IV  
***Alternative regimen (2): [[Vancomycin]] 15 mg/kg IV for 7-10 days
***Alternative regimen (3): Ciprofloxacin 400 mg IV
***Alternative regimen (3): [[Ciprofloxacin]] 400 mg IV for 10 days
***Alternative regimen (4): levofloxacin 500 mg IV
***Alternative regimen (4): [[levofloxacin]] 500 mg IV for 5 days
***Alternative regimen (5): Aztreonam 2 g IV
***Alternative regimen (5): [[Aztreonam]] 2 g IV q 6-8h (not to exceed 8g/day)
**Topical medications  
**'''3. Topical medications'''
***Lidocaine
***[[Lidocaine]]
***Capsaicin’s analgesic
***[[Capsaicin]]’s analgesic


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
{{WH}}
{{WS}}


[[Category:Needs content]]
[[Category:Needs content]]
[[Category:Surgery]]
[[Category:Surgery]]
[[Category:Gastroenterology]]
[[Category:Gastroenterology]]
[[Category:Primary care]]
{{WH}}
{{WS}}

Latest revision as of 22:25, 29 July 2020

Inguinal hernia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Inguinal hernia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Inguinal hernia medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Inguinal hernia medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Inguinal hernia medical therapy

CDC on Inguinal hernia medical therapy

Inguinal hernia medical therapy in the news

Blogs on Inguinal hernia medical therapy

Directions to Hospitals Treating Inguinal hernia

Risk calculators and risk factors for Inguinal hernia medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Farima Kahe M.D. [2]

Overview

Pharmacologic medical therapies for inguinal hernia include pain reliever, antibiotics, topical medications.

Medical Therapy

  • Pharmacologic medical therapies for patients with post-operative repair of inguinal hernia include:[1][2][3][4]
    • 1. Pain reliever
    • 2. Antibiotics
      • Preferred regimen: Cefazolin 2 g IV for 7 days
      • Alternative regimen (1): Clindamycin 900 mg q 8h for 7 days
      • Alternative regimen (2): Vancomycin 15 mg/kg IV for 7-10 days
      • Alternative regimen (3): Ciprofloxacin 400 mg IV for 10 days
      • Alternative regimen (4): levofloxacin 500 mg IV for 5 days
      • Alternative regimen (5): Aztreonam 2 g IV q 6-8h (not to exceed 8g/day)
    • 3. Topical medications

References

  1. Bjurstrom MF, Nicol AL, Amid PK, Chen DC (2014). "Pain control following inguinal herniorrhaphy: current perspectives". J Pain Res. 7: 277–90. doi:10.2147/JPR.S47005. PMC 4045265. PMID 24920934.
  2. Cohen SP, Galvagno SM, Plunkett A, Harris D, Kurihara C, Turabi A, Rehrig S, Buckenmaier CC, Chelly JE (2013). "A multicenter, randomized, controlled study evaluating preventive etanercept on postoperative pain after inguinal hernia repair". Anesth. Analg. 116 (2): 455–62. doi:10.1213/ANE.0b013e318273f71c. PMID 23302973.
  3. Derry S, Sven-Rice A, Cole P, Tan T, Moore RA (2013). "Topical capsaicin (high concentration) for chronic neuropathic pain in adults". Cochrane Database Syst Rev (2): CD007393. doi:10.1002/14651858.CD007393.pub3. PMID 23450576.
  4. O'Connor AB, Dworkin RH (2009). "Treatment of neuropathic pain: an overview of recent guidelines". Am. J. Med. 122 (10 Suppl): S22–32. doi:10.1016/j.amjmed.2009.04.007. PMID 19801049.

Template:WH Template:WS